Intravenous immunoglobulin in the treatment of Guillain-Barre syndrome

dc.contributor.authorElevli M.
dc.contributor.authorYaramis A.
dc.contributor.authorSoker M.
dc.contributor.authorHaspolat K.
dc.contributor.authorGunbey S.
dc.date.accessioned2024-04-24T18:44:04Z
dc.date.available2024-04-24T18:44:04Z
dc.date.issued1997
dc.departmentDicle Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.identifier.endpage104en_US
dc.identifier.issn1300-0144
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-0031045384
dc.identifier.scopusqualityQ1
dc.identifier.startpage103en_US
dc.identifier.urihttps://hdl.handle.net/11468/24542
dc.identifier.volume27en_US
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGuillain-Barre Syndromeen_US
dc.subjectİntravenous İmmunoglobulin (Ivıg)en_US
dc.titleIntravenous immunoglobulin in the treatment of Guillain-Barre syndromeen_US
dc.titleIntravenous immunoglobulin in the treatment of Guillain-Barre syndrome
dc.typeArticleen_US

Dosyalar